|
|
 |
|
ALNY: Alnylam Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 24, 2009 |
Alnylam Pharm (ALNY) Downgrade Alert, Watch for 20.9% Technical Downtrend Continuation |
| Nov 24, 2009 |
Analyst Downgrades for November 24th |
| Nov 21, 2009 |
Alnylam Pharmaceuticals Down 21.5% Since SmarTrend's Sell Recommendation |
| Nov 19, 2009 |
BiomedReports: News and FDA Updates for Affymax (Nasdaq:AFFY), Alnylam (Nasdaq:ALNY), BSD Medical (NASDAQ:BSDM) |
| Nov 18, 2009 |
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 18, 2009 : DSTI, AATI, SHMR and ALNY |
| Nov 18, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: ALNY, ARYC |
| Nov 18, 2009 |
Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer |
| Nov 15, 2009 |
Alnylam Pharmaceuticals Down 19.9% Since SmarTrend's Sell Recommendation |
| Nov 13, 2009 |
BiomedReports: News and FDA Updates for Abbott (NYSE:ABT), Alnylam (Nasdaq:ALNY), CellCyte (OTC:CCYG) |
| Nov 12, 2009 |
Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day |
| Nov 10, 2009 |
BiomedReports: News and FDA Updates for Alnylam (Nasdaq:ALNY), Antares (NYSE:AIS), Biogen (NASDAQ:BIIB) |
| Nov 09, 2009 |
Alnylam to Webcast R&D Day on Thursday, November 12, 2009 |
| Nov 06, 2009 |
Alnylam Pharmaceuticals Down 24.4% Since SmarTrend's Sell Recommendation |
| Nov 05, 2009 |
Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting |
| Nov 04, 2009 |
Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance |
| |
| ZACKS COMMENTARY FOR ALNY |
|
|
|
Sponsored Links 
-0.57